Brainstorm Cell Therapeutics Inc (BCLI)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché BCLI Giù? Forum Previsione Frazionamento azionario

Perché le azioni Brainstorm Cell Therapeutics Inc (BCLI) sono in ribasso?

Abbiamo notato un calo di 7.04% nelle azioni di Brainstorm Cell Therapeutics Inc (BCLI) durante la sessione di negoziazione di 2024-09-06. Sebbene ciò possa essere attribuito alla normale volatilità o a vari fattori interni ed esterni, tieni presente che stiamo monitorando attivamente la situazione e forniremo aggiornamenti tempestivi il prima possibile!

2023-09-28:

Shares of Brainstorm Cell Therapeutics Inc. (BCLI) were down 47.73% to $0.20 after the company announced the FDA Advisory Committee voted that NurOwn did not demonstrate substantial evidence of effectiveness for treatment of mild to moderate ALS.

https://www.benzinga.com/news/earnings/23/09/34981141/crude-oil-moves-lower-carmax-posts-downbeat-earnings

2023-09-25:

Brainstorm Cell Therapeutics Inc. (BCLI) fell 47.57% to $0.4277 after the FDA said it does not believe there is sufficient evidence to support that any of the assessed biomarkers for the company's ALS therapy is reasonably likely to predict clinical benefit.

https://www.benzinga.com/news/23/09/34873722/why-brainstorm-cell-therapeutics-shares-are-trading-lower-by-33-here-are-other-stocks-moving-in-mond